Pyrotinib in combination with first-line trastuzumab and docetaxel for patients with HER2-positive metastatic breast cancer: a new therapeutic option?
Authors: Pier Paolo M. Berton Giachetti, Giuseppe Curigliano
Published: 2023-12-19
DOI:
10.1038/s41571-023-00854-y
Source:
Full article
Abstract
No abstract found.